sibutramine has been researched along with natriuretic peptide, brain in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Algul, B; Arif Yalcin, A; Ata, N; Dal, K; Kucukazman, M; Okhan Akin, K; Sinan Deveci, O; Taner Ertugrul, D; Tutal, E; Yavuz, B | 1 |
1 other study(ies) available for sibutramine and natriuretic peptide, brain
| Article | Year |
|---|---|
An obesity drug sibutramine reduces brain natriuretic peptide (BNP) levels in severely obese patients.
Topics: Appetite Depressants; Biomarkers; Body Mass Index; Cholesterol, LDL; Cyclobutanes; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Obesity | 2010 |